News & Updates

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in significant weight loss in patients with obesity or overweight without diabetes, a study has shown. In addition, the best GLP-1RA agent appears to be semaglutide, showing superior efficacy and low-to-moderate risk of side effects.

Aldosterone synthase inhibition with lorundrostat confers substantial blood pressure (BP)-lowering benefit in people with uncontrolled hypertension, while having a favourable safety profile, according to data from the phase II Target-HTN trial.

Treatment with electrofulguration for antibiotic-refractory recurrent urinary tract infections (UTI) demonstrates durable clinical cure and improvement over 5 years in menopausal women, reducing the need for long-term antibiotics, a study has shown.

Type 1 diabetes (T1D) is significantly associated with the risk of sexual dysfunction among women, according to the results of a systematic review and meta-analysis.

Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) appears to increase the risk of venous thromboembolism (VTE) in women using hormonal contraception, reveals a study.

Treatment with low-dose spironolactone results in reduced albuminuria without causing hyperkalaemia in patients with type 2 diabetes (T2D), reports a study.

Individuals with higher genetically predicted plasma cortisol appear to have greater odds of hypertension, according to a Mendelian randomization analysis.